Quest Diagnostics Inc (DGX)
NYSE
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 6.43 | 7.494 | 6.845 | 7.196 | 10.652 | 14.437 | 7.154 | 6.359 |
Return on Equity (%) | 13.763 | 16.058 | 14.4 | 15.666 | 22.903 | 30.018 | 15.242 | 13.918 |
Return on Invested Capital (%) | 11.869 | 14.546 | 13.193 | 12.725 | 17.622 | 17.846 | 12.905 | 10.859 |
Operating Margin (%) | 16.367 | 15.346 | 14.54 | 16.257 | 21.723 | 25.501 | 13.994 | 13.975 |
Net Profit Margin (%) | 8.583 | 10.014 | 9.773 | 11.105 | 15.164 | 18.493 | 9.572 | 9.23 |
Book Value Per Share | -16.146 | -17.919 | -17.97 | -14.865 | -8.639 | -14.286 | -20.766 | -22.066 |
Earnings Per Share | 4.708 | 5.719 | 5.452 | 6.451 | 10.759 | 16.765 | 8.523 | 7.595 |
Cash Per Share | 2.62 | 1.015 | 1 | 8.962 | 8.707 | 7.328 | 2.838 | 6.101 |
Working Capital Per Share | 4.015 | 1.844 | -0.704 | 3.759 | 9.639 | 8.303 | 3.126 | 4.954 |
Operating Profit Per Share | 23.409 | 23.6 | 21.022 | 22.684 | 29.256 | 37.95 | 33.784 | 30.097 |
EBIT Per Share | 7.927 | 7.63 | 6.859 | 8.09 | 14.165 | 21.84 | 11.126 | 10.05 |
EBITDA Per Share | 7.927 | 7.63 | 6.859 | 8.09 | 14.165 | 21.84 | 11.126 | 10.05 |
Free Cash Flow Per Share | 6.715 | 7.415 | 8.03 | 9.135 | 13.459 | 19.303 | 10.973 | 10.157 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 137M | 135M | 135M | 133M | 133M | 119M | 111M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 111M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 13.471 | N/A | N/A | N/A | 13.314 | N/A | N/A |
Net Profit Margin (%) | N/A | 8.666 | N/A | N/A | N/A | 8.199 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 16.91B |
Price to Earnings Ratio | 20.01 |
Price to Sales Ratio | 1.85 |
Price to Cash Ratio | 24.91 |
Price to Book Ratio | 2.66 |
Dividend Yield | 184.30% |
Shares Outstanding | 111.62M |
Average Volume (1 week) | 940.6k |
Average Volume (1 Month) | 836.76k |
52 Week Change | 12.74% |
52 Week High | 165.32 |
52 Week Low | 123.04 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.